Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
Novo Nordisk (stock symbol: NVO) dividend yield (TTM) as of January 05, 2025 : 1.64%Average dividend yield, last 5 years: 1.27%